Strata Critical Medical Inc
SRTA
93 hedge funds and large institutions have $126M invested in Strata Critical Medical Inc in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 19 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
2.77% less ownership
Funds ownership: 54.54% → 51.77% (-2.8%)
3% less funds holding
Funds holding: 96 → 93 (-3)
10% less capital invested
Capital invested by funds: $140M → $126M (-$14.2M)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
62% less call options, than puts
Call options by funds: $794K | Put options by funds: $2.08M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$10.2M |
| 2 |
JGC
J. Goldman & Co
New York
|
+$1.04M |
| 3 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
+$308K |
| 4 |
NL
NKCFO LLC
Geneva,
Illinois
|
+$265K |
| 5 |
Renaissance Technologies
New York
|
+$182K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HVCM
HG Vora Capital Management
New York
|
-$13.8M |
| 2 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$1.32M |
| 3 |
CSCSIM
Clear Sky Carbon Solutions Investment Management
Bellaire,
Texas
|
-$1.29M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$801K |
| 5 |
ICM
Ionic Capital Management
New York
|
-$622K |
SRTA Hedge Fund Activity: Q1 2023 in Review
93 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q1 2023, worth a combined $126M — down 10% from $140M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of SRTA and 16 opened new positions — a net loss of 3 holders — while 22 trimmed existing stakes and 27 added.
The largest buyer was Goldman Sachs, adding an estimated $10.2M. The largest seller was HG Vora Capital Management, cutting an estimated $13.8M.
- 93 institutional investors held Strata Critical Medical Inc (SRTA) as of Q1 2023, down from 96 in Q4 2022.
- Funds reported $126M of Strata Critical Medical Inc stock for Q1 2023, down 10% quarter-over-quarter.
- 16 funds opened new Strata Critical Medical Inc positions in Q1 2023 and 19 closed out, a net change of -3 holders.
- The largest Strata Critical Medical Inc buyer in Q1 2023 was Goldman Sachs, an estimated $10.2M added.
- The largest Strata Critical Medical Inc seller in Q1 2023 was HG Vora Capital Management, an estimated $13.8M sold.
Based on aggregated 13F filings for Q1 2023.